VRCA — Verrica Pharmaceuticals Balance Sheet
0.000.00%
HealthcareSpeculativeSmall CapNeutral
- $191.91m
- $152.46m
- $12.00m
Annual balance sheet for Verrica Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8.66 | 89.8 | 62 | 65.5 | 70.4 |
Prepaid Expenses | |||||
Total Current Assets | 9.08 | 91.2 | 65 | 67.7 | 74.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0.255 | 2.2 | 4.94 | 5.5 |
Other Long Term Assets | |||||
Total Assets | 9.08 | 91.9 | 68.4 | 74.2 | 80.1 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.616 | 2.48 | 3.35 | 39.5 | 46.1 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.616 | 2.48 | 3.41 | 41.2 | 47.5 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 8.47 | 89.4 | 65 | 33 | 32.6 |
Total Liabilities & Shareholders' Equity | 9.08 | 91.9 | 68.4 | 74.2 | 80.1 |
Total Common Shares Outstanding |